SCHEMBL10637102

SCHEMBL10637102

O=c1[nH]cnc2cc3ccccc3nc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 8/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
PDPK1 O15530 1/20 0.53
CA12 O43570 1/20 0.53
ALOX15 P16050 1/20 0.53
CA9 Q16790 1/20 0.53
TNKS2 Q9H2K2 1/20 0.53
ADORA3 P0DMS8 1/20 0.45
ALDH1A1 P00352 3/20 0.44
HPGD P15428 2/20 0.44
KDM4E B2RXH2 1/20 0.44
GAA P10253 1/20 0.44
TSHR P16473 1/20 0.44
HTT P42858 1/20 0.44
HSD17B10 Q99714 1/20 0.44
MAPT P10636 2/20 0.42
GLA P06280 1/20 0.42
ACHE P22303 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13981736 0.75 ALDH1A1 (0.63) PARP1SMN1; SMN2PDPK1CA12ALOX15
SCHEMBL29744436 0.75 PARP1 (0.61) PARP1SMN1; SMN2PDPK1CA12ALOX15
SCHEMBL2921734 0.75 PARP1 (0.61) PARP1SMN1; SMN2PDPK1CA12ALOX15
SCHEMBL11547422 0.75 SRC (0.56) PARP1SMN1; SMN2PDPK1CA12ALOX15
SCHEMBL10637092 0.75 PDE3B (0.46) PARP1SMN1; SMN2PDPK1CA12ALOX15
SCHEMBL8131559 0.74 PARP1 (0.51) PARP1SMN1; SMN2PDPK1CA12ALOX15
SCHEMBL325052 0.71 PARP1 (0.55) PARP1SMN1; SMN2PDPK1CA12ALOX15
SCHEMBL23353120 0.70 ALDH1A1 (0.50) PARP1SMN1; SMN2PDPK1CA12ALOX15
SCHEMBL30590804 0.70 PARP1 (0.45) PARP1SMN1; SMN2PDPK1CA12ALOX15
SCHEMBL26112788 0.70 PARP1 (0.45) PARP1SMN1; SMN2PDPK1CA12ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119497615-A TPK agonists and methods of using the same for treating neurodegenerative diseases 上海日馨医药科技股份有限公司 2025-02-21 CN disclosed
EP-0163257-B1 PHOTOPOLYMERISABLE MIXTURE CONTAINING 1,3,10-TRIAZAANTHRACEN-4-ONE AS A PHOTOINITIATOR HOECHST AKTIENGESELLSCHAFT (DE) 1988-07-13 EP disclosed
EP-0163257-B1 PHOTOPOLYMERISABLE MIXTURE CONTAINING 1,3,10-TRIAZAANTHRACEN-4-ONE AS A PHOTOINITIATOR HOECHST AKTIENGESELLSCHAFT (DE) 1988-07-13 EP disclosed
US-4619885-A PHOTORESISTS HOECHST AKTIENGESELLSCHAFT (DE) 1986-10-28 US disclosed
EP-0163257-A1 Photopolymerisable mixture containing 1,3,10-triazaanthracen-4-one as a photoinitiator HOECHST AKTIENGESELLSCHAFT (DE) 1985-12-04 EP disclosed
EP-0163257-A1 Photopolymerisable mixture containing 1,3,10-triazaanthracen-4-one as a photoinitiator HOECHST AKTIENGESELLSCHAFT (DE) 1985-12-04 EP disclosed
EP-0163257-A1 Photopolymerisable mixture containing 1,3,10-triazaanthracen-4-one as a photoinitiator HOECHST AKTIENGESELLSCHAFT (DE) 1985-12-04 EP disclosed